Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:

This session focuses on the critical role of vaccine development in the response to HIV. This session addresses all scientists and clinicians concerned with the genesis of novel HIV vaccine candidates towards their efficacy in clinical trials. Speakers will discuss the ongoing need to get an effective vaccine to win the war against HIV in the current ART landscape. Additionally, the latest discoveries with regards to vaccine design and trials in humans will highlight where we stand today in our endeavour to develop a successful HIV vaccine.

11:00
MOSY0401
Introduction
11:05
MOSY0402
How close are we to the perfect vaccine?
Glenda Gray, South Africa
11:15
MOSY0403
Progress in antibody-mediated preventive vaccine strategies
Hanneke Schuitemaker, Netherlands
Slides
11:25
MOSY0404
VAC -3S: a gp41 therapeutical vaccine increasing CD4 cells in patients under HART
Patrice Debré, France
Slides
11:35
MOSY0405
Experimental medicine clinical trials of promising new HIV candidates
Robin Shattock, United Kingdom
Slides
11:45
MOSY0406
Conserved epitope based vaccines
Tomas Hanke, United Kingdom
11:55
MOSY0407
Moderated discussion
12:25
MOSY0408
Closing remarks